CHEMOTHERAPY IN CHRONIC BRONCHITIS BRrmrs_N_ 303 MEDICAL JOURATABLE A.-Nasal Staphylococcal Carrier Rates at the Beginning and End of the Trial Coagulase-positive Staphylococci No. of No. of No. Resistant to: Clinics Patients No. NoReitnt: Isolated Penicillin Tetracycline Before trial 15 180 38 (21%) 4 (2%) 3 (2%) After ,, 10 134 25 (19%) 6 (5%) 10 (8%)especially those resistant to tetracycline. Little significance can be attached to these results, however, since they take no account of the treatment to which each patient had been exposed.Results in Different Treatment Groups More detailed analysis of the results in relation to treatment groups is given in Table B. It is unfortunate that the distribution of staphylococcal carriers at the beginning of TABLE B.-Results in Different Treatment Groups Beginning of Trial End of Trial Treat-No. of ment Patients No. of R.
A child with acute lymphoblastic leukaemia, being treated in the UKALL II Trial, had while in remission an attack of measles and made a normal recovery. Four months later she developed an acute encephalopathy and died within two weeks. The brain showed mild inflammatory features and widespread inclusion bodies in neurones and glial cells. Immunofluorescence proved an infection with measles virus. Similar cases have been called SSPE; reasons are given for preferring the term "measles inclusion-body encephalitis".
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.